Connect with us

Technology

Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda

Published

4 hours ago

on

Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities in Latin America at premier Life Sciences event

LONDON, Oct. 4, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 2nd annual Summit LATAM, which will be held in Milan on October 7, 2024, ahead of the CPHI Milan conference. In partnership with the Brazilian Association of the Pharmaceutical Ingredients Industry (Abiquifi), this year’s event reinforces the industry’s commitment to patient welfare by showcasing how collective efforts and innovative strategies are reshaping the pharmaceutical ecosystem, with a focus on navigating market challenges and uncovering innovation opportunities.

In the wake of the pandemic, the global pharmaceutical industry faced a slowdown in growth, prompting companies to swiftly identify new opportunities and areas of innovation. As the Latin American market is valued at $98 billion,1 with projected growth of 10.1%—outpacing North America (3.1%) and Europe (3.9%)—navigating this region is crucial for the future of the global pharmaceutical landscape. To maintain a competitive edge and ensure return on investment, organizations must adopt effective, cross-functional solutions. Summit LATAM 2024 will offer attendees the chance to explore obstacles, discover new opportunities, and discuss strategies for accelerating development processes in the region.

Henry Levy, President, Life Sciences and Healthcare, Clarivate, said: “At Clarivate, we have been committed to driving innovation and delivering strategic solutions in Latin America for over two decades. Our mission is to foster collaboration across the life sciences and healthcare sectors, empowering organizations to navigate the evolving pharmaceutical landscape. We are proud to unite industry leaders through Clarivate Summit LATAM, in partnership with ABIQUIFI, to address the region’s most pressing challenges and unlock new opportunities for growth and innovation.” 

Norberto Prestes, President, Abiquifi, said: “There can be no serious and efficient planning if we don’t have quality data. Abiquifi has innovation as a priority part of its strategy and to this end we are expanding our partnership with Clarivate so that we can carry out a quality LATAM mobilization in order to expand the production and development of innovative IFAS in the bloc. The meetings we hold in each country are guided by the data provided by Clarivate. The high-quality information brings the LATAM reality to the center of discussions and helps us define priorities, understand where there are opportunities to act in the medium term and what we should invest in long-term research in the region.” 

Cristian Madoery, Director Sales Latam, Life Sciences and Healthcare, Clarivate, said: “Summit LATAM Milan offers a valuable opportunity to connect with key leaders in the Latin American pharmaceutical sector. Clarivate has been actively fostering an ecosystem in Latin America, bringing together diverse players to strengthen the region’s immense professional and technological potential. Platforms like this are enriching for all involved, providing a unique chance to share ideas, exchange knowledge, and learn from one another.”

This year’s agenda features insights and perspectives from industry leaders and analysts, with sessions focused on innovative partnerships, artificial intelligence, regulatory guidelines and API production. Noteworthy sessions include:

From information to innovation: Driving growth in Latin America with data and artificial intelligence, presentation by Cristian Madoery, Director Sales Latam, Life Sciences & Healthcare, Clarivate and Leticia Terra, Solutions Consultant, Life Sciences and Healthcare, Clarivate    Interactions and partnerships in Latin America: Strategy or survival? Identifying and executing competitive partnership, panel discussion by Stephani Saverio, VP Business Development, Knight Therapeutics, Juliana Megid, Institutional Relations Director, EMS, Federico Rivera, Business Development, Gene Pharm and Anna Paula Guembes, New Business Director, Libbs Farmacêutica Implementation of regulatory guidelines attractive to the market and aimed at optimizing access to the population, by Marcus Aurelio Miranda de Araujo, General Manager of GGFIS, ANVISA Local API production: What’s missing in Latin America? With strategies based on the search for sustainable raw materials, panel discussion by Norberto Prestes, Executive President, Abiquifi, Marcelo Mansur, CEO, Nortec and Javier Mestre, General Manager, Emcure Mexico and José Ézio Nogueira, CEO, Globe Química  

Notes to editors

Summit LATAM takes place on Monday, October 7, 2024, at the Hotel NH Collection, Milan. Register to attend and learn more on this premier event, here or here.

Meet the Clarivate Latam team at Pharma Connection, hosted by Abiquifi on October 7, 2024 at Hotel NH Collection, Milan at 9:00 AM. Learn more, here.

Following the summit, join the Clarivate team of life sciences and healthcare experts at CPHI Milan 2024 from Oct 8-10 at booth 14F84 or at the Brazilian Delegation. Learn how to transform complex markets, API, and regulatory data into actionable insights. Meet with the Clarivate team, here. 

Connect with Clarivate Life Sciences and Healthcare. Join the conversation and mention Clarivate and Summit LATAM on X and LinkedIn. #SummitLATAM #PatientCare #Pharma #Clarivate #ThinkForward 

About Abiquifi

Founded in 1983, the Brazilian Association of the Pharmaceutical Ingredients Industry (Abiquifi) is a non-profit organization that brings together the main companies in the pharma-chemical sector in Brazil. Our mission is to promote the development and production of pharmaceutical ingredients in the country, meeting the demands of the domestic industry and strengthening Brazil’s presence on the international market. With the support of our members, government agencies and other institutions representing the sector, Abiquifi leads strategic initiatives to increase the competitiveness and visibility of the national industry.

About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media Contact:
Luna Ivkovic
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com

1 Source: PharmaBoardroom. (2022). Infigures: Latin America 2022. https://pharmaboardroom.com/country-reports/infigures-latin-america-2022/

 

SOURCE Clarivate Plc

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Enghouse Systems Limited Announces Resignation of its President and Transition of Responsibilities

Published

55 seconds ago

on

October 4, 2024

By

MARKHAM, ON, Oct. 4, 2024 /CNW/ – Enghouse Systems Limited (TSX: ENGH) today announced that Vince Mifsud, President, has tendered his resignation from the Company to pursue another opportunity. His departure will be effective December 2024, upon completion of the 2024 Enghouse fiscal year. Mr. Mifsud will transition his responsibilities to Steve Sadler, Chairman and CEO of Enghouse prior to his departure. The Company intends to conduct a comprehensive search for Mr. Mifsud’s replacement. 

“We are committed to ensuring a seamless transition and maintaining our strategic momentum,” said Mr. Sadler. “I look forward to guiding the team through this period and continuing to drive value for our shareholders.”

The Company wishes Mr. Mifsud the best in his new endeavor and thanks him for his dedication and many contributions over the seven years he has been with Enghouse.

About Enghouse Systems Limited

Enghouse Systems Ltd. is a Canadian publicly traded company (TSX:ENGH) that provides vertically focused enterprise software solutions focusing on contact centers, video communications, healthcare, telecommunications, public safety and the transit market. Enghouse has a two-pronged growth strategy that focuses on internal growth and acquisitions, which are funded through operating cash flows. The company has no external debt financing and is organized around two business segments: the Interactive Management Group and the Asset Management Group. Further information about Enghouse may be obtained from the company’s website at www.enghouse.com.

SOURCE Enghouse Systems Limited

Continue Reading

Technology

/R E P E A T — MEDIA ADVISORY – Canada, Manitoba, and Giganawenimaanaanig to take a step forward on Red Dress Alert/

Published

57 seconds ago

on

October 4, 2024

By

WINNIPEG, MB, Oct. 3, 2024 /CNW/ – Please be advised that the Honourable Gary Anandasangaree, Minister of Crown-Indigenous Relations, and the Honourable Nahanni Fontaine, Minister of Families of Manitoba, will make an announcement about the Red Dress Alert pilot at Giganawenimaanaanig’s Day of Education and Awareness.

There will be a media availability following the announcement.

Media participation:

Media representatives are asked to RSVP to RCAANC.media.CIRNAC@sac-isc.gc.ca.

Virtual participation will be available, and instructions to connect remotely will be provided upon registration.

Media are first invited to observe Ministerial remarks and engagement with families, survivors, MMIWG advocates and frontline workers at 11:30 a.m. The media availability will follow in an adjoining room.

Date:  Friday, October 4, 2024
Time: The announcement will start at 11:30 a.m. (CT), followed by the media availability.

Media representatives are invited to preposition 30 minutes before the start time of the event.

Where:
Canad Inns Destination Centre Club Regent Casino Hotel
1415 Regent Ave W
Winnipeg, Manitoba

The announcement will take place in the Grand Ballroom, and the media availability will take place in the Ambassador E.

Follow us on X:

GovCan – Indigenous
(https://twitter.com/GCIndigenous)
Manitoba Government
(https://x.com/mbgov)

SOURCE Crown-Indigenous Relations and Northern Affairs Canada

Continue Reading

Technology

Loblaw Companies Limited Enters into Automatic Share Purchase Plan

Published

59 seconds ago

on

October 4, 2024

By

BRAMPTON, ON, Oct. 4, 2024 /CNW/ – Loblaw Companies Limited (TSX: L) “Loblaw”) announced today that it has entered into an automatic share purchase plan (“ASPP”) with a broker in order to facilitate repurchases of Loblaw’s common shares (“Common Shares”) under its previously announced normal course issuer bid (“NCIB”). 

Loblaw previously announced that it had received approval from the Toronto Stock Exchange (“TSX”) to, during the 12-month period commencing May 6, 2024 and terminating May 5, 2025, purchase up to 15,336,875 Common Shares, representing approximately 5% of the 306,737,513 Common Shares issued and outstanding as of April 22, 2024, by way of a NCIB on the TSX or through alternative trading systems or by such other means as may be permitted under applicable law.

During the effective period of Loblaw’s ASPP, Loblaw’s broker may purchase Common Shares at times when Loblaw would not be active in the market due to insider trading rules and its own internal trading blackout periods. Purchases will be made by Loblaw’s broker based upon parameters set by Loblaw when it is not in possession of any material non-public information about itself and its securities, and in accordance with the terms of the ASPP. Outside of the effective period of the ASPP, Common Shares may continue to be purchased in accordance with Loblaw’s discretion, subject to applicable law. The ASPP has been entered into in accordance with the requirements of applicable Canadian securities laws.

About Loblaw Companies Limited

Loblaw is Canada’s food and pharmacy leader, and the nation’s largest retailer. Loblaw provides Canadians with grocery, pharmacy, health and beauty, apparel, general merchandise, financial services and wireless mobile products and services. With more than 2,500 corporate franchised and Associate-owned locations, Loblaw, its franchisees and Associate-owners employ more than 220,000 full- and part-time employees, making it one of Canada’s largest private sector employers.

Loblaw’s purpose – Live Life Well® – puts first the needs and well-being of Canadians who make one billion transactions annually in the company’s stores. Loblaw is positioned to meet and exceed those needs in many ways: convenient locations; more than 1,100 grocery stores that span the value spectrum from discount to specialty; full-service pharmacies at nearly 1,400 Shoppers Drug Mart® and Pharmaprix® locations and close to 500 Loblaw locations; PC Financial® services; Joe Fresh® fashion and family apparel; and four of Canada’s top-consumer brands in Life Brand®, Farmer’s Market™, no name® and President’s Choice®. For more information, visit Loblaw’s website at www.loblaw.ca and Loblaw’s issuer profile at www.sedarplus.ca.

SOURCE Loblaw Companies Limited

Continue Reading

Trending